nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—ABCB1—Topotecan—cervical cancer	0.448	0.625	CbGbCtD
Indinavir—CYP3A4—Topotecan—cervical cancer	0.269	0.375	CbGbCtD
Indinavir—Neuralgia—Topotecan—cervical cancer	0.0121	0.055	CcSEcCtD
Indinavir—Hyperbilirubinaemia—Topotecan—cervical cancer	0.00923	0.042	CcSEcCtD
Indinavir—Respiratory failure—Topotecan—cervical cancer	0.00855	0.0389	CcSEcCtD
Indinavir—Anaphylactoid reaction—Topotecan—cervical cancer	0.0063	0.0287	CcSEcCtD
Indinavir—Cramp muscle—Topotecan—cervical cancer	0.00549	0.025	CcSEcCtD
Indinavir—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.00549	0.025	CcSEcCtD
Indinavir—Alanine aminotransferase increased—Topotecan—cervical cancer	0.00537	0.0245	CcSEcCtD
Indinavir—Weight increased—Topotecan—cervical cancer	0.00479	0.0218	CcSEcCtD
Indinavir—Pneumonia—Topotecan—cervical cancer	0.00472	0.0215	CcSEcCtD
Indinavir—Neuropathy peripheral—Topotecan—cervical cancer	0.0046	0.021	CcSEcCtD
Indinavir—Sweating—Topotecan—cervical cancer	0.0045	0.0205	CcSEcCtD
Indinavir—Hepatobiliary disease—Topotecan—cervical cancer	0.00444	0.0202	CcSEcCtD
Indinavir—Haemoglobin—Topotecan—cervical cancer	0.00424	0.0193	CcSEcCtD
Indinavir—Haemorrhage—Topotecan—cervical cancer	0.00422	0.0192	CcSEcCtD
Indinavir—Hypoaesthesia—Topotecan—cervical cancer	0.00419	0.0191	CcSEcCtD
Indinavir—Pharyngitis—Topotecan—cervical cancer	0.00418	0.019	CcSEcCtD
Indinavir—Immune system disorder—Topotecan—cervical cancer	0.00381	0.0173	CcSEcCtD
Indinavir—Chills—Topotecan—cervical cancer	0.00378	0.0172	CcSEcCtD
Indinavir—Alopecia—Topotecan—cervical cancer	0.00373	0.017	CcSEcCtD
Indinavir—Malnutrition—Topotecan—cervical cancer	0.00367	0.0167	CcSEcCtD
Indinavir—SLCO1B1—renal system—cervical cancer	0.00365	0.0578	CbGeAlD
Indinavir—Back pain—Topotecan—cervical cancer	0.00355	0.0162	CcSEcCtD
Indinavir—Muscle spasms—Topotecan—cervical cancer	0.00353	0.0161	CcSEcCtD
Indinavir—Ill-defined disorder—Topotecan—cervical cancer	0.00341	0.0155	CcSEcCtD
Indinavir—Anaemia—Topotecan—cervical cancer	0.00339	0.0154	CcSEcCtD
Indinavir—Angioedema—Topotecan—cervical cancer	0.00335	0.0153	CcSEcCtD
Indinavir—Malaise—Topotecan—cervical cancer	0.00331	0.0151	CcSEcCtD
Indinavir—Cough—Topotecan—cervical cancer	0.0032	0.0146	CcSEcCtD
Indinavir—Chest pain—Topotecan—cervical cancer	0.00312	0.0142	CcSEcCtD
Indinavir—Arthralgia—Topotecan—cervical cancer	0.00312	0.0142	CcSEcCtD
Indinavir—Myalgia—Topotecan—cervical cancer	0.00312	0.0142	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.0031	0.0141	CcSEcCtD
Indinavir—Discomfort—Topotecan—cervical cancer	0.00309	0.0141	CcSEcCtD
Indinavir—SLC22A1—renal system—cervical cancer	0.00308	0.0488	CbGeAlD
Indinavir—Anaphylactic shock—Topotecan—cervical cancer	0.003	0.0136	CcSEcCtD
Indinavir—SLCO1A2—renal system—cervical cancer	0.00297	0.047	CbGeAlD
Indinavir—Nervous system disorder—Topotecan—cervical cancer	0.00294	0.0134	CcSEcCtD
Indinavir—Thrombocytopenia—Topotecan—cervical cancer	0.00293	0.0133	CcSEcCtD
Indinavir—SLCO1B1—female reproductive system—cervical cancer	0.00292	0.0463	CbGeAlD
Indinavir—Skin disorder—Topotecan—cervical cancer	0.00291	0.0132	CcSEcCtD
Indinavir—Hyperhidrosis—Topotecan—cervical cancer	0.0029	0.0132	CcSEcCtD
Indinavir—Anorexia—Topotecan—cervical cancer	0.00286	0.013	CcSEcCtD
Indinavir—ABCC2—renal system—cervical cancer	0.00277	0.0438	CbGeAlD
Indinavir—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00273	0.0124	CcSEcCtD
Indinavir—Paraesthesia—Topotecan—cervical cancer	0.00269	0.0122	CcSEcCtD
Indinavir—Dyspnoea—Topotecan—cervical cancer	0.00267	0.0122	CcSEcCtD
Indinavir—Dyspepsia—Topotecan—cervical cancer	0.00264	0.012	CcSEcCtD
Indinavir—ABCC1—uterine cervix—cervical cancer	0.0026	0.0412	CbGeAlD
Indinavir—Decreased appetite—Topotecan—cervical cancer	0.0026	0.0119	CcSEcCtD
Indinavir—Gastrointestinal disorder—Topotecan—cervical cancer	0.00259	0.0118	CcSEcCtD
Indinavir—Fatigue—Topotecan—cervical cancer	0.00258	0.0118	CcSEcCtD
Indinavir—Constipation—Topotecan—cervical cancer	0.00256	0.0117	CcSEcCtD
Indinavir—Pain—Topotecan—cervical cancer	0.00256	0.0117	CcSEcCtD
Indinavir—ABCC1—decidua—cervical cancer	0.00248	0.0393	CbGeAlD
Indinavir—Feeling abnormal—Topotecan—cervical cancer	0.00247	0.0112	CcSEcCtD
Indinavir—Gastrointestinal pain—Topotecan—cervical cancer	0.00245	0.0111	CcSEcCtD
Indinavir—Urticaria—Topotecan—cervical cancer	0.00238	0.0108	CcSEcCtD
Indinavir—Body temperature increased—Topotecan—cervical cancer	0.00237	0.0108	CcSEcCtD
Indinavir—Abdominal pain—Topotecan—cervical cancer	0.00237	0.0108	CcSEcCtD
Indinavir—ABCC1—endometrium—cervical cancer	0.00236	0.0373	CbGeAlD
Indinavir—ABCC1—mammalian vulva—cervical cancer	0.00228	0.0361	CbGeAlD
Indinavir—SLC22A1—vagina—cervical cancer	0.00223	0.0354	CbGeAlD
Indinavir—ABCC2—female reproductive system—cervical cancer	0.00222	0.0351	CbGeAlD
Indinavir—Hypersensitivity—Topotecan—cervical cancer	0.00221	0.01	CcSEcCtD
Indinavir—ABCC1—uterus—cervical cancer	0.00217	0.0344	CbGeAlD
Indinavir—Asthenia—Topotecan—cervical cancer	0.00215	0.00978	CcSEcCtD
Indinavir—Pruritus—Topotecan—cervical cancer	0.00212	0.00965	CcSEcCtD
Indinavir—Diarrhoea—Topotecan—cervical cancer	0.00205	0.00933	CcSEcCtD
Indinavir—CYP3A5—uterine cervix—cervical cancer	0.002	0.0317	CbGeAlD
Indinavir—Dizziness—Topotecan—cervical cancer	0.00198	0.00901	CcSEcCtD
Indinavir—Vomiting—Topotecan—cervical cancer	0.0019	0.00867	CcSEcCtD
Indinavir—Rash—Topotecan—cervical cancer	0.00189	0.0086	CcSEcCtD
Indinavir—Dermatitis—Topotecan—cervical cancer	0.00189	0.00859	CcSEcCtD
Indinavir—Headache—Topotecan—cervical cancer	0.00188	0.00854	CcSEcCtD
Indinavir—CYP3A5—renal system—cervical cancer	0.00187	0.0297	CbGeAlD
Indinavir—Nausea—Topotecan—cervical cancer	0.00178	0.0081	CcSEcCtD
Indinavir—ABCC1—female gonad—cervical cancer	0.00178	0.0281	CbGeAlD
Indinavir—ABCC1—vagina—cervical cancer	0.00176	0.028	CbGeAlD
Indinavir—CYP2C19—vagina—cervical cancer	0.00172	0.0273	CbGeAlD
Indinavir—CYP2C9—female reproductive system—cervical cancer	0.00148	0.0234	CbGeAlD
Indinavir—CYP3A4—renal system—cervical cancer	0.00141	0.0223	CbGeAlD
Indinavir—CYP2D6—renal system—cervical cancer	0.00138	0.0219	CbGeAlD
Indinavir—CYP3A5—female gonad—cervical cancer	0.00136	0.0216	CbGeAlD
Indinavir—CYP3A5—vagina—cervical cancer	0.00136	0.0215	CbGeAlD
Indinavir—ABCC2—lymph node—cervical cancer	0.0013	0.0205	CbGeAlD
Indinavir—ABCC1—lymph node—cervical cancer	0.00114	0.0181	CbGeAlD
Indinavir—CYP3A4—female reproductive system—cervical cancer	0.00113	0.0178	CbGeAlD
Indinavir—CYP2D6—female reproductive system—cervical cancer	0.00111	0.0175	CbGeAlD
Indinavir—ABCB1—epithelium—cervical cancer	0.00107	0.017	CbGeAlD
Indinavir—ABCB1—uterine cervix—cervical cancer	0.00106	0.0168	CbGeAlD
Indinavir—ABCB1—decidua—cervical cancer	0.00101	0.016	CbGeAlD
Indinavir—CYP2D6—female gonad—cervical cancer	0.00101	0.016	CbGeAlD
Indinavir—ABCB1—renal system—cervical cancer	0.000995	0.0158	CbGeAlD
Indinavir—ABCB1—endometrium—cervical cancer	0.000962	0.0152	CbGeAlD
Indinavir—ABCB1—mammalian vulva—cervical cancer	0.00093	0.0147	CbGeAlD
Indinavir—ABCB1—uterus—cervical cancer	0.000886	0.014	CbGeAlD
Indinavir—ABCB1—female reproductive system—cervical cancer	0.000797	0.0126	CbGeAlD
Indinavir—ABCB1—female gonad—cervical cancer	0.000725	0.0115	CbGeAlD
Indinavir—ABCB1—vagina—cervical cancer	0.00072	0.0114	CbGeAlD
Indinavir—ABCB1—lymph node—cervical cancer	0.000466	0.00738	CbGeAlD
